Their study illustrated that ABCA10 facilitates lipid metabolism reprogramming by promoting mitochondrial cholesterol efflux, thereby increasing the sensitivity of ovarian cancer cells to cisplatin (DDP). This evidence concerns the gene ABCA10 and ovarian carcinoma.